- Home
- ICUI vs RLX Comparison
ICUI vs RLX Comparison
Compare ICUI & RLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICUI
- RLX
- Stock Information
- Founded
- ICUI 1984
- RLX 2018
- Country
- ICUI United States
- RLX China
- Employees
- ICUI N/A
- RLX N/A
- Industry
- ICUI Medical/Dental Instruments
- RLX Medicinal Chemicals and Botanical Products
- Sector
- ICUI Health Care
- RLX Health Care
- Exchange
- ICUI Nasdaq
- RLX Nasdaq
- Market Cap
- ICUI 3.0B
- RLX 2.8B
- IPO Year
- ICUI 1992
- RLX 2021
- Fundamental
- Price
- ICUI $133.13
- RLX $2.61
- Analyst Decision
- ICUI Buy
- RLX Hold
- Analyst Count
- ICUI 6
- RLX 1
- Target Price
- ICUI $186.60
- RLX $2.25
- AVG Volume (30 Days)
- ICUI 314.3K
- RLX 4.4M
- Earning Date
- ICUI 11-11-2025
- RLX 08-22-2025
- Dividend Yield
- ICUI N/A
- RLX 0.37%
- EPS Growth
- ICUI N/A
- RLX 12.15
- EPS
- ICUI N/A
- RLX 0.08
- Revenue
- ICUI $2,372,504,000.00
- RLX $407,348,055.00
- Revenue This Year
- ICUI N/A
- RLX $27.26
- Revenue Next Year
- ICUI N/A
- RLX $19.61
- P/E Ratio
- ICUI N/A
- RLX $33.83
- Revenue Growth
- ICUI 2.96
- RLX 55.36
- 52 Week Low
- ICUI $107.00
- RLX $1.57
- 52 Week High
- ICUI $196.26
- RLX $2.84
- Technical
- Relative Strength Index (RSI)
- ICUI 60.24
- RLX 63.69
- Support Level
- ICUI $121.61
- RLX $2.51
- Resistance Level
- ICUI $136.61
- RLX $2.84
- Average True Range (ATR)
- ICUI 3.76
- RLX 0.10
- MACD
- ICUI 1.09
- RLX 0.02
- Stochastic Oscillator
- ICUI 78.47
- RLX 54.46
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
About RLX RLX Technology Inc. each representing the right to receive one (1) ordinary share
RLX Technology Inc is engaged in the manufacturing of e-vapor products for adult smokers. It has an integrated offline distribution and "Branded store plus" retail model tailored to China's e-vapor market.